Pasteur Institute of Lille

ILiAD Biotechnologies Receives NIH Grant to Develop Novel Tuberculosis Vaccine using proprietary B-Tech Vector Platform

Retrieved on: 
Tuesday, April 26, 2022

ILiADs B-Tech Vector Platform utilizes a proprietary attenuated Bordetella pertussis (B. pertussis) strain as an intranasal vaccine vector to express pathogen target antigens, inducing both systemic and respiratory mucosal immunologic responses.

Key Points: 
  • ILiADs B-Tech Vector Platform utilizes a proprietary attenuated Bordetella pertussis (B. pertussis) strain as an intranasal vaccine vector to express pathogen target antigens, inducing both systemic and respiratory mucosal immunologic responses.
  • B-Tech Vector Platform vaccines have demonstrated immunogenicity in 8 peer-reviewed published pre-clinical studies targeting viruses, bacteria, and parasites.
  • In addition to preclinical development of B-Tech Vector vaccines for TB and other targets, ILiAD continues to advance its BPZE1 pertussis vaccine through late-stage clinical development.
  • ILiAD Biotechnologies is utilizing its B-Tech technology to develop next generation vaccines to prevent infectious diseases and improve lives.

AirLabs Announces U.S. Launch of AirBubbl Personal Portable Air Purifier

Retrieved on: 
Tuesday, September 28, 2021

AirBubbl is a truly portable purifier, designed to transition from the home, to our vehicles, and into offices, hotels, or anywhere else people want to breathe safe, clean air.

Key Points: 
  • AirBubbl is a truly portable purifier, designed to transition from the home, to our vehicles, and into offices, hotels, or anywhere else people want to breathe safe, clean air.
  • AirLabs' air filtration and air quality monitoring systems are already in use by transport operators, cities, and businesses across the world to mitigate the harmful effects of air pollution.
  • The AirBubbl personal, portable air purifier is the result of AirLabs' in-lab development and real-world testing, pushing the boundaries of technology to achieve personal protection from insidious and rampant pollution in our environment.
  • "A single AirBubbl produces 10,000 gallons of clean, filtered air per hour, which is world-leading in terms of Clean Air Delivery Rate (CADR)," said AirLabs' Chief Science Officer Matthew Johnson.

Moskitofree Launches Aeriashield

Retrieved on: 
Monday, September 14, 2020

The service of Doctor Michle Vialette, Head of Service of the Microbiological Safety Unit, responsible for the High Safety Laboratory at the Pasteur Institute in Lille, supervised the tests on the Aeriashield devices.

Key Points: 
  • The service of Doctor Michle Vialette, Head of Service of the Microbiological Safety Unit, responsible for the High Safety Laboratory at the Pasteur Institute in Lille, supervised the tests on the Aeriashield devices.
  • The Aeriashield by Moskitofree device, tested by the Institut Pasteur De Lille, eliminates 99% of the human coronavirus HCoV-229E within 5 minutes in the air of a sealed enclosure (1.4 m3).
  • Aeriashield by Moskitofree is available in 2 models: individual (portable device) and collective (device to be placed on a table).
  • Aeriashield by Moskitofree provides an eective complementary response to fight against airborne contamination.